---
title: CRO Daily News — November 11, 2026
slug: daily-news-2026-11-11-cro
site: cro
post_kind: news
byline: BioBM
description: November 11 CRO daily: Key Considerations for Smaller Biotechs in APAC Phase III Trials — Smaller biotechs can leverage faster recruitment and lower costs in…
canonical_url: https://www.cro.directory/posts/daily-news-2026-11-11-cro
published_at: 2026-11-11T23:59:46.845Z
last_updated: 2026-11-12T00:01:02.157Z
---

### Key Considerations for Smaller Biotechs in APAC Phase III Trials
- Smaller biotechs must align country selection with marketing authorization plans to succeed in APAC Phase III trials.
- Choosing the right sites and partnering with a CRO that has regional experience and KOL networks are critical for effective trial execution.

**Operational Impact**

Smaller biotechs can leverage faster recruitment and lower costs in APAC, particularly in oncology, to improve trial outcomes.

*Source: [Applied Clinical Trials RSS](https://www.appliedclinicaltrialsonline.com/view/smaller-biotechs-right-first-apac-phase-trial)*

## References

1. [Applied Clinical Trials RSS — Key Considerations for Smaller Biotechs in APAC Phase III Trials](https://www.appliedclinicaltrialsonline.com/view/smaller-biotechs-right-first-apac-phase-trial)

Source: https://www.cro.directory/posts/daily-news-2026-11-11-cro